Get the Stockscreener App
2.27
0.89%
0.02
After Hours:
2.27
Evolent Health Inc stock is traded at $2.27, with a volume of 4.53M.
It is up +0.89% in the last 24 hours and down -27.71% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$2.25
Open:
$2.27
24h Volume:
4.53M
Relative Volume:
1.46
Market Cap:
$253.42M
Revenue:
$1.88B
Net Income/Loss:
$-534.51M
P/E Ratio:
-0.4409
EPS:
-5.1483
Net Cash Flow:
$4.76M
1W Performance:
-14.98%
1M Performance:
-27.71%
6M Performance:
-74.55%
1Y Performance:
-75.67%
1-Day Range:
$2.19
$2.34
1-Week Range:
$2.19
$2.815
52-Week Range:
$2.19
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.27 | 251.19M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Aug Setups: How sensitive is Evolent Health Inc to inflation2026 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Will Evolent Health Inc benefit from geopolitical trendsEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Macro: How does Evolent Health Inc score in quality rankings2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent HealthNews and Statistics - IndexBox
Evolent announces appointment of Archie Mayani as chief product officer - The AI Journal
Evolent Health Appoints New Chief Product Officer - Intellectia AI
Doctor behind Cityblock joins Foodsmart to expand food as medicine for Medicaid - Stock Titan
Evolent Health at Oppenheimer Conference: Strategic Growth and Financial Focus - Investing.com Canada
EVH: Strong pipeline, conservative guidance, and focus on profitability drive growth outlook - TradingView
Fund Flows: What is the next catalyst for Evolent Health Inc2026 Review & Pattern Based Trade Signal System - baoquankhu1.vn
Forecast Cut: Is Evolent Health Inc currently under institutional pressure2026 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Eventide Asset Management LLC Purchases 2,205,659 Shares of Evolent Health, Inc $EVH - MarketBeat
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH - MarketBeat
Investor Alert: Unprofitable Companies with High Financial Risk in 2026News and Statistics - IndexBox
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50-Day Moving AverageHere's What Happened - MarketBeat
Aug Analyst Calls: What is Evolent Health Incs 5 year growth outlookQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Gainers Report: How sensitive is Evolent Health Inc to inflationMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
How Evolent Health Inc Class stock expands through international markets2026 Macro Impact & Verified Trade Idea Suggestions - Naître et grandir
Precision Trading with Evolent Health Inc Class A (EVH) Risk Zones - Stock Traders Daily
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage - Yahoo Finance
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Profit Recap: Is Madison Square Garden Entertainment Corp stock influenced by commodity pricesWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Evolent Health (NYSE: EVH) CEO reports PSU grant and tax-withheld share dispositions - Stock Titan
Evolent Health (EVH) president awarded PSUs and withholds shares for taxes - Stock Titan
Evolent Health (EVH) CAO awarded PSUs while shares withheld for taxes - Stock Titan
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
Evolent Health (NYSE: EVH) GC logs PSU grant and tax-share withholdings - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Wall Street Zen Upgrades Evolent Health Stock Rating - National Today
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Yahoo Finance
EVH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
Evolent Health price target lowered to $4 by Citigroup - National Today
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
5.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):